Literature DB >> 15382101

Economic analysis of VenUS I, a randomized trial of two bandages for treating venous leg ulcers.

C P Iglesias1, E A Nelson, N Cullum, D J Torgerson.   

Abstract

BACKGROUND: The study investigated the cost-effectiveness of four-layer and short-stretch compression bandages for treating venous leg ulcers.
METHODS: Cost-effectiveness and cost-utility analyses were performed using patient-level data collected alongside the VenUS I leg ulcer study. The perspective for the economic analysis was that of the UK National Health Service (NHS) and Personal Social Service. The time horizon for the analysis was 1 year after recruitment. Health benefit was measured as differences in ulcer-free days and quality-adjusted life years (QALYs).
RESULTS: The mean healing time for ulcers treated with four-layer bandages was 10.9 (95 per cent confidence interval (c.i.) -6.8 to 29.1) days less than that for ulcers treated with short-stretch bandages. Mean average difference in QALYs between compression systems was -0.02 (95 per cent c.i. -0.08 to 0.04). The four-layer bandage cost a mean of pound 227.32 (95 per cent c.i. pound 16.53 to pound 448 .30) less per patient per year than the short-stretch bandage.
CONCLUSION: On average, four-layer bandaging was associated with greater health benefits and lower costs than short-stretch bandaging. Copyright (c) 2004 British Journal of Surgery Society Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15382101     DOI: 10.1002/bjs.4755

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  The impact of providing product funding for compression bandaging and medical footwear on compression use, wound healing and quality of life.

Authors:  Suzanne Kapp; Charne Miller; Kylie Elder
Journal:  Int Wound J       Date:  2011-12-16       Impact factor: 3.315

Review 2.  Improved wound management at lower cost: a sensible goal for Australia.

Authors:  Rosana E Norman; Michelle Gibb; Anthony Dyer; Jennifer Prentice; Stephen Yelland; Qinglu Cheng; Peter A Lazzarini; Keryln Carville; Karen Innes-Walker; Kathleen Finlayson; Helen Edwards; Edward Burn; Nicholas Graves
Journal:  Int Wound J       Date:  2015-12-03       Impact factor: 3.315

Review 3.  Compression for preventing recurrence of venous ulcers.

Authors:  E Andrea Nelson; Sally E M Bell-Syer
Journal:  Cochrane Database Syst Rev       Date:  2014-09-09

4.  Venous ulcer review.

Authors:  Paul Bevis; Jonothan Earnshaw
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-03-03

5.  Wound cleansing for treating venous leg ulcers.

Authors:  Niamh Em McLain; Zena Eh Moore; Pinar Avsar
Journal:  Cochrane Database Syst Rev       Date:  2021-03-10

Review 6.  A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types.

Authors:  Andrea C Tricco; Elise Cogo; Wanrudee Isaranuwatchai; Paul A Khan; Geetha Sanmugalingham; Jesmin Antony; Jeffrey S Hoch; Sharon E Straus
Journal:  BMC Med       Date:  2015-04-22       Impact factor: 8.775

Review 7.  Compression for venous leg ulcers.

Authors:  Susan O'Meara; Nicky Cullum; E Andrea Nelson; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

8.  Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging Trial.

Authors:  Ba' Pham; Margaret B Harrison; Maggie H Chen; Meg E Carley
Journal:  BMC Health Serv Res       Date:  2012-10-02       Impact factor: 2.655

9.  Compression bandages or stockings versus no compression for treating venous leg ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Emma Connaughton; Gill Norman
Journal:  Cochrane Database Syst Rev       Date:  2021-07-26

10.  Cost-effectiveness of interventions for increasing the possession of functioning smoke alarms in households with pre-school children: a modelling study.

Authors:  Pedro Saramago; Nicola J Cooper; Alex J Sutton; Mike Hayes; Ken Dunn; Andrea Manca; Denise Kendrick
Journal:  BMC Public Health       Date:  2014-05-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.